{"id":5044,"date":"2022-02-22T22:22:49","date_gmt":"2022-02-22T22:22:49","guid":{"rendered":"https:\/\/www.ast-inc.com\/?p=5044"},"modified":"2022-05-25T16:27:43","modified_gmt":"2022-05-25T16:27:43","slug":"considerations-for-pre-filled-syringes-for-503b-compounding-facilities","status":"publish","type":"post","link":"https:\/\/www.ast-inc.com\/whitepapers\/considerations-for-pre-filled-syringes-for-503b-compounding-facilities\/","title":{"rendered":"Considerations for Pre-filled Syringes for 503(b) Compounding Facilities"},"content":{"rendered":"\n<p>AST, a leading aseptic fill- and finishing machine manufacturer, and SCHOTT, a global expert in drug containment solutions, share their expertise on how to help 503(b) compounding facilities bring acute care drugs to market quicker, provide a safer drug administration process, and minimize healthcare and hospital costs.<\/p>\n\n\n\n<div class=\"wp-block-columns gated-form is-layout-flex wp-container-core-columns-is-layout-28f84493 wp-block-columns-is-layout-flex\">\n<div class=\"wp-block-column is-layout-flow wp-block-column-is-layout-flow\">\n\n<div class=\"wpcf7 no-js\" id=\"wpcf7-f5052-o1\" lang=\"en-US\" dir=\"ltr\" data-wpcf7-id=\"5052\">\n<div class=\"screen-reader-response\"><p role=\"status\" aria-live=\"polite\" aria-atomic=\"true\"><\/p> <ul><\/ul><\/div>\n<form action=\"\/wp-json\/wp\/v2\/posts\/5044#wpcf7-f5052-o1\" method=\"post\" class=\"wpcf7-form init\" aria-label=\"Contact form\" novalidate=\"novalidate\" data-status=\"init\">\n<fieldset class=\"hidden-fields-container\"><input type=\"hidden\" name=\"_wpcf7\" value=\"5052\" \/><input type=\"hidden\" name=\"_wpcf7_version\" value=\"6.1.4\" \/><input type=\"hidden\" name=\"_wpcf7_locale\" value=\"en_US\" \/><input type=\"hidden\" name=\"_wpcf7_unit_tag\" value=\"wpcf7-f5052-o1\" \/><input type=\"hidden\" name=\"_wpcf7_container_post\" value=\"0\" \/><input type=\"hidden\" name=\"_wpcf7_posted_data_hash\" value=\"\" \/><input type=\"hidden\" name=\"_wpcf7cf_hidden_group_fields\" value=\"[]\" \/><input type=\"hidden\" name=\"_wpcf7cf_hidden_groups\" value=\"[]\" \/><input type=\"hidden\" name=\"_wpcf7cf_visible_groups\" value=\"[]\" \/><input type=\"hidden\" name=\"_wpcf7cf_repeaters\" value=\"[]\" \/><input type=\"hidden\" name=\"_wpcf7cf_steps\" value=\"{}\" \/><input type=\"hidden\" name=\"_wpcf7cf_options\" value=\"{&quot;form_id&quot;:5052,&quot;conditions&quot;:[],&quot;settings&quot;:{&quot;animation&quot;:&quot;yes&quot;,&quot;animation_intime&quot;:200,&quot;animation_outtime&quot;:200,&quot;conditions_ui&quot;:&quot;normal&quot;,&quot;notice_dismissed&quot;:false,&quot;notice_dismissed_update-cf7-5.5.6&quot;:true,&quot;notice_dismissed_rollback-cf7-5.9.2&quot;:true}}\" \/><input type=\"hidden\" name=\"_wpcf7_recaptcha_response\" value=\"\" \/>\n<\/fieldset>\n<div class=\"uacf7-form-wrapper-container uacf7-form-5052  \"><h3>To Read the Full Article\u00a0Please Complete The Form:<\/h3>\n<div class=\"fieldset\" role=\"group\">\n\t<div class=\"input-group\">\n<label>Name<\/label>\n    <span class=\"wpcf7-form-control-wrap\" data-name=\"fullname\"><input size=\"40\" maxlength=\"400\" class=\"wpcf7-form-control wpcf7-text wpcf7-validates-as-required\" aria-required=\"true\" aria-invalid=\"false\" placeholder=\"Name\" value=\"\" type=\"text\" name=\"fullname\" \/><\/span>\n<\/div>\n<div class=\"input-group\">\n<label>Email<\/label>\n    <span class=\"wpcf7-form-control-wrap\" data-name=\"email\"><input size=\"40\" maxlength=\"400\" class=\"wpcf7-form-control wpcf7-email wpcf7-validates-as-required wpcf7-text wpcf7-validates-as-email\" aria-required=\"true\" aria-invalid=\"false\" placeholder=\"Email\" value=\"\" type=\"email\" name=\"email\" \/><\/span>\n<\/div>\n<div class=\"input-group\">\n<label>Company<\/label>\n    <span class=\"wpcf7-form-control-wrap\" data-name=\"company\"><input size=\"40\" maxlength=\"400\" class=\"wpcf7-form-control wpcf7-text wpcf7-validates-as-required\" aria-required=\"true\" aria-invalid=\"false\" placeholder=\"Company\" value=\"\" type=\"text\" name=\"company\" \/><\/span> \n<\/div>\n<div class=\"input-group\">\n<label>Job Title<\/label>\n    <span class=\"wpcf7-form-control-wrap\" data-name=\"jobtitle\"><input size=\"40\" maxlength=\"400\" class=\"wpcf7-form-control wpcf7-text wpcf7-validates-as-required\" aria-required=\"true\" aria-invalid=\"false\" placeholder=\"Job Title\" value=\"\" type=\"text\" name=\"jobtitle\" \/><\/span> \n<\/div>\n<div class=\"input-group\">\n<input class=\"wpcf7-form-control wpcf7-submit has-spinner\" type=\"submit\" value=\"Submit\" \/>\n<\/div>\n<\/div><\/div><div class=\"wpcf7-response-output\" aria-hidden=\"true\"><\/div>\n<\/form>\n<\/div>\n\n<\/div>\n<\/div>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>AST, a leading aseptic fill- and finishing machine manufacturer, and SCHOTT, a global expert in drug containment solutions, share their expertise on how to help 503(b) compounding facilities bring acute care drugs to market quicker, provide a safer drug administration process, and minimize healthcare and hospital costs.<\/p>\n","protected":false},"author":8,"featured_media":5233,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[194],"tags":[],"class_list":["post-5044","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-whitepapers"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Considerations For Pre-Filled Syringes For 503(B) Compounding Facilities<\/title>\n<meta name=\"description\" content=\"AST shares their expertise on how to help 503(b) compounding facilities bring acute care drugs to market quicker. Click to read more.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ast-inc.com\/whitepapers\/considerations-for-pre-filled-syringes-for-503b-compounding-facilities\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Considerations For Pre-Filled Syringes For 503(B) Compounding Facilities\" \/>\n<meta property=\"og:description\" content=\"AST shares their expertise on how to help 503(b) compounding facilities bring acute care drugs to market quicker. Click to read more.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ast-inc.com\/whitepapers\/considerations-for-pre-filled-syringes-for-503b-compounding-facilities\/\" \/>\n<meta property=\"og:site_name\" content=\"AST, Inc.\" \/>\n<meta property=\"article:published_time\" content=\"2022-02-22T22:22:49+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-05-25T16:27:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ast-inc.com\/wp-content\/uploads\/2022\/02\/Thumbnail-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1751\" \/>\n\t<meta property=\"og:image:height\" content=\"1329\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Brittany Hoff\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.ast-inc.com\/whitepapers\/considerations-for-pre-filled-syringes-for-503b-compounding-facilities\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.ast-inc.com\/whitepapers\/considerations-for-pre-filled-syringes-for-503b-compounding-facilities\/\"},\"author\":{\"name\":\"Brittany Hoff\",\"@id\":\"https:\/\/www.ast-inc.com\/#\/schema\/person\/f61b2c3b0f104fbaa3beff6fd02a6e01\"},\"headline\":\"Considerations for Pre-filled Syringes for 503(b) Compounding Facilities\",\"datePublished\":\"2022-02-22T22:22:49+00:00\",\"dateModified\":\"2022-05-25T16:27:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.ast-inc.com\/whitepapers\/considerations-for-pre-filled-syringes-for-503b-compounding-facilities\/\"},\"wordCount\":55,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.ast-inc.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.ast-inc.com\/whitepapers\/considerations-for-pre-filled-syringes-for-503b-compounding-facilities\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.ast-inc.com\/wp-content\/uploads\/2022\/02\/Thumbnail-1.jpg\",\"articleSection\":[\"Whitepaper\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ast-inc.com\/whitepapers\/considerations-for-pre-filled-syringes-for-503b-compounding-facilities\/\",\"url\":\"https:\/\/www.ast-inc.com\/whitepapers\/considerations-for-pre-filled-syringes-for-503b-compounding-facilities\/\",\"name\":\"Considerations For Pre-Filled Syringes For 503(B) Compounding Facilities\",\"isPartOf\":{\"@id\":\"https:\/\/www.ast-inc.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.ast-inc.com\/whitepapers\/considerations-for-pre-filled-syringes-for-503b-compounding-facilities\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.ast-inc.com\/whitepapers\/considerations-for-pre-filled-syringes-for-503b-compounding-facilities\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.ast-inc.com\/wp-content\/uploads\/2022\/02\/Thumbnail-1.jpg\",\"datePublished\":\"2022-02-22T22:22:49+00:00\",\"dateModified\":\"2022-05-25T16:27:43+00:00\",\"description\":\"AST shares their expertise on how to help 503(b) compounding facilities bring acute care drugs to market quicker. Click to read more.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.ast-inc.com\/whitepapers\/considerations-for-pre-filled-syringes-for-503b-compounding-facilities\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ast-inc.com\/whitepapers\/considerations-for-pre-filled-syringes-for-503b-compounding-facilities\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ast-inc.com\/whitepapers\/considerations-for-pre-filled-syringes-for-503b-compounding-facilities\/#primaryimage\",\"url\":\"https:\/\/www.ast-inc.com\/wp-content\/uploads\/2022\/02\/Thumbnail-1.jpg\",\"contentUrl\":\"https:\/\/www.ast-inc.com\/wp-content\/uploads\/2022\/02\/Thumbnail-1.jpg\",\"width\":1751,\"height\":1329,\"caption\":\"Considerations for Pre-filled Syringes for 503(b) Compounding Facilities\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ast-inc.com\/whitepapers\/considerations-for-pre-filled-syringes-for-503b-compounding-facilities\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.ast-inc.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Considerations for Pre-filled Syringes for 503(b) Compounding Facilities\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ast-inc.com\/#website\",\"url\":\"https:\/\/www.ast-inc.com\/\",\"name\":\"AST, Inc.\",\"description\":\"Industrial equipment supplier\",\"publisher\":{\"@id\":\"https:\/\/www.ast-inc.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ast-inc.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.ast-inc.com\/#organization\",\"name\":\"AST\",\"alternateName\":\"AST\",\"url\":\"https:\/\/www.ast-inc.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ast-inc.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.ast-inc.com\/wp-content\/uploads\/2021\/11\/AST-Logo-Hi-Res.png\",\"contentUrl\":\"https:\/\/www.ast-inc.com\/wp-content\/uploads\/2021\/11\/AST-Logo-Hi-Res.png\",\"width\":2622,\"height\":952,\"caption\":\"AST\"},\"image\":{\"@id\":\"https:\/\/www.ast-inc.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.ast-inc.com\/#\/schema\/person\/f61b2c3b0f104fbaa3beff6fd02a6e01\",\"name\":\"Brittany Hoff\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ast-inc.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/d8c2ba5152a644c663e1945425d70d334368caed6a3ce113f5dae3420ca9b099?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/d8c2ba5152a644c663e1945425d70d334368caed6a3ce113f5dae3420ca9b099?s=96&d=mm&r=g\",\"caption\":\"Brittany Hoff\"},\"url\":\"https:\/\/www.ast-inc.com\/author\/bhoff\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Considerations For Pre-Filled Syringes For 503(B) Compounding Facilities","description":"AST shares their expertise on how to help 503(b) compounding facilities bring acute care drugs to market quicker. Click to read more.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ast-inc.com\/whitepapers\/considerations-for-pre-filled-syringes-for-503b-compounding-facilities\/","og_locale":"en_US","og_type":"article","og_title":"Considerations For Pre-Filled Syringes For 503(B) Compounding Facilities","og_description":"AST shares their expertise on how to help 503(b) compounding facilities bring acute care drugs to market quicker. Click to read more.","og_url":"https:\/\/www.ast-inc.com\/whitepapers\/considerations-for-pre-filled-syringes-for-503b-compounding-facilities\/","og_site_name":"AST, Inc.","article_published_time":"2022-02-22T22:22:49+00:00","article_modified_time":"2022-05-25T16:27:43+00:00","og_image":[{"width":1751,"height":1329,"url":"https:\/\/www.ast-inc.com\/wp-content\/uploads\/2022\/02\/Thumbnail-1.jpg","type":"image\/jpeg"}],"author":"Brittany Hoff","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.ast-inc.com\/whitepapers\/considerations-for-pre-filled-syringes-for-503b-compounding-facilities\/#article","isPartOf":{"@id":"https:\/\/www.ast-inc.com\/whitepapers\/considerations-for-pre-filled-syringes-for-503b-compounding-facilities\/"},"author":{"name":"Brittany Hoff","@id":"https:\/\/www.ast-inc.com\/#\/schema\/person\/f61b2c3b0f104fbaa3beff6fd02a6e01"},"headline":"Considerations for Pre-filled Syringes for 503(b) Compounding Facilities","datePublished":"2022-02-22T22:22:49+00:00","dateModified":"2022-05-25T16:27:43+00:00","mainEntityOfPage":{"@id":"https:\/\/www.ast-inc.com\/whitepapers\/considerations-for-pre-filled-syringes-for-503b-compounding-facilities\/"},"wordCount":55,"commentCount":0,"publisher":{"@id":"https:\/\/www.ast-inc.com\/#organization"},"image":{"@id":"https:\/\/www.ast-inc.com\/whitepapers\/considerations-for-pre-filled-syringes-for-503b-compounding-facilities\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ast-inc.com\/wp-content\/uploads\/2022\/02\/Thumbnail-1.jpg","articleSection":["Whitepaper"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.ast-inc.com\/whitepapers\/considerations-for-pre-filled-syringes-for-503b-compounding-facilities\/","url":"https:\/\/www.ast-inc.com\/whitepapers\/considerations-for-pre-filled-syringes-for-503b-compounding-facilities\/","name":"Considerations For Pre-Filled Syringes For 503(B) Compounding Facilities","isPartOf":{"@id":"https:\/\/www.ast-inc.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.ast-inc.com\/whitepapers\/considerations-for-pre-filled-syringes-for-503b-compounding-facilities\/#primaryimage"},"image":{"@id":"https:\/\/www.ast-inc.com\/whitepapers\/considerations-for-pre-filled-syringes-for-503b-compounding-facilities\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ast-inc.com\/wp-content\/uploads\/2022\/02\/Thumbnail-1.jpg","datePublished":"2022-02-22T22:22:49+00:00","dateModified":"2022-05-25T16:27:43+00:00","description":"AST shares their expertise on how to help 503(b) compounding facilities bring acute care drugs to market quicker. Click to read more.","breadcrumb":{"@id":"https:\/\/www.ast-inc.com\/whitepapers\/considerations-for-pre-filled-syringes-for-503b-compounding-facilities\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ast-inc.com\/whitepapers\/considerations-for-pre-filled-syringes-for-503b-compounding-facilities\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ast-inc.com\/whitepapers\/considerations-for-pre-filled-syringes-for-503b-compounding-facilities\/#primaryimage","url":"https:\/\/www.ast-inc.com\/wp-content\/uploads\/2022\/02\/Thumbnail-1.jpg","contentUrl":"https:\/\/www.ast-inc.com\/wp-content\/uploads\/2022\/02\/Thumbnail-1.jpg","width":1751,"height":1329,"caption":"Considerations for Pre-filled Syringes for 503(b) Compounding Facilities"},{"@type":"BreadcrumbList","@id":"https:\/\/www.ast-inc.com\/whitepapers\/considerations-for-pre-filled-syringes-for-503b-compounding-facilities\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ast-inc.com\/"},{"@type":"ListItem","position":2,"name":"Considerations for Pre-filled Syringes for 503(b) Compounding Facilities"}]},{"@type":"WebSite","@id":"https:\/\/www.ast-inc.com\/#website","url":"https:\/\/www.ast-inc.com\/","name":"AST, Inc.","description":"Industrial equipment supplier","publisher":{"@id":"https:\/\/www.ast-inc.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ast-inc.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.ast-inc.com\/#organization","name":"AST","alternateName":"AST","url":"https:\/\/www.ast-inc.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ast-inc.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.ast-inc.com\/wp-content\/uploads\/2021\/11\/AST-Logo-Hi-Res.png","contentUrl":"https:\/\/www.ast-inc.com\/wp-content\/uploads\/2021\/11\/AST-Logo-Hi-Res.png","width":2622,"height":952,"caption":"AST"},"image":{"@id":"https:\/\/www.ast-inc.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.ast-inc.com\/#\/schema\/person\/f61b2c3b0f104fbaa3beff6fd02a6e01","name":"Brittany Hoff","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ast-inc.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/d8c2ba5152a644c663e1945425d70d334368caed6a3ce113f5dae3420ca9b099?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d8c2ba5152a644c663e1945425d70d334368caed6a3ce113f5dae3420ca9b099?s=96&d=mm&r=g","caption":"Brittany Hoff"},"url":"https:\/\/www.ast-inc.com\/author\/bhoff\/"}]}},"_links":{"self":[{"href":"https:\/\/www.ast-inc.com\/wp-json\/wp\/v2\/posts\/5044","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ast-inc.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ast-inc.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ast-inc.com\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ast-inc.com\/wp-json\/wp\/v2\/comments?post=5044"}],"version-history":[{"count":0,"href":"https:\/\/www.ast-inc.com\/wp-json\/wp\/v2\/posts\/5044\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ast-inc.com\/wp-json\/wp\/v2\/media\/5233"}],"wp:attachment":[{"href":"https:\/\/www.ast-inc.com\/wp-json\/wp\/v2\/media?parent=5044"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ast-inc.com\/wp-json\/wp\/v2\/categories?post=5044"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ast-inc.com\/wp-json\/wp\/v2\/tags?post=5044"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}